Discover
Visualize rapid, validated insights through real-world data.
Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company. Learn more →
Ulka Campbell is the Head of Scientific Strategy at Aetion and provides methodological and regulatory expertise on studies across therapeutic areas and leads research to inform regulatory RWE best practices. Previously, she was at Pfizer for 14 years working in the regulatory epidemiology group and later as the Head of Safety Surveillance Research at Pfizer.